Cargando...
Tiotropium formulations and safety: a network meta-analysis
Tiotropium is now delivered via two different inhaler devices: the original Handihaler 18 μg once daily, which uses a powder formulation; and the newer Respimat Soft Mist Inhaler (SMI) 5 μg once daily. It has been questioned whether the two devices can be assumed to have the same safety profile, alt...
Guardado en:
| Publicado en: | Ther Adv Drug Saf |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5298465/ https://ncbi.nlm.nih.gov/pubmed/28203364 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098616667304 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|